🇪🇺 Linzess in European Union

Linzess (LINACLOTIDE) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002490
  • Local brand name: Constella
  • Status: approved

Linzess in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in European Union

Frequently asked questions

Is Linzess approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Linzess in European Union?

AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.